name of chinese digital currency Top People searches

Market News: Argentine President Milei met with Rio Tinto CEO Meloni in Rome.Dai Hongwei, a professor at the Central University of Finance and Economics: We must give full play to the advantages of central cities in scientific and technological innovation. Dai Hongwei, a professor and doctoral supervisor at the Central University of Finance and Economics, believes that it is necessary to actively cultivate new growth poles for innovation to drive regional economic growth. We must give full play to the radiation-driven role of central cities, especially in the context of innovation-driven development. We must pay attention to giving full play to the advantages of central cities in scientific and technological innovation, driving the development of surrounding areas, accelerating the development of new quality productivity, and at the same time give full play to the important role of urban agglomerations in promoting collaborative innovation and group development. (SSE)Minister of Agriculture of Ukraine: Ukraine is willing and ready to supply food to Syria.

Xinxiangwei: Shareholder Xinyu Yijiade intends to reduce its shareholding by no more than 1%. Xinxiangwei announced that as of the disclosure date, Shareholder Xinyu Yijiade holds 20,175,800 shares of the company, accounting for 4.39% of the company's total share capital. Xinyu Yijiade plans to reduce the number of shares of the company by no more than 4,595,300 shares through centralized bidding or block trading of Shanghai Stock Exchange within 90 days after 15 trading days from the date of announcement, and the proportion of reduced shares in the company's total share capital is no more than 1%.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Market News: Turkish anti-monopoly agency fined Google $75 million for advertising technology investigation.

COMEX silver fell 2.00% in the day and is now quoted at $30.99 per ounce. COMEX silver fell to $31 per ounce, down 1.97% in the day.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Haitian Weiye, a soy sauce manufacturer, is reported to have hired a bank to handle the listing in Hong Kong. According to informed sources, Haitian Weiye, one of the largest condiment manufacturers in China, has hired CICC, Goldman Sachs and Morgan Stanley to handle the second listing in Hong Kong, which may raise at least $1.5 billion. According to people familiar with the matter, Haitian plans to submit a preliminary prospectus to the Hong Kong Stock Exchange as early as January.